Human Genome Epidemiology Literature Finder
Records 1 - 3 (of 3 Records) |
Query Trace: Syndrome and JAK1[original query] |
---|
JAK1, but not JAK2 and STAT3, confers susceptibility to Vogt-Koyanagi-Harada (VKH) syndrome in a Han Chinese population. Investigative ophthalmology & visual science 2013 May 54 (5): 3360-5. Hu Ke, Hou Shengping, Li Fuzhen, Xiang Qin, Kijlstra Aize, Yang Peize |
Clinical and genomic characterisation of mismatch repair deficient pancreatic adenocarcinoma. Gut 2020 9 70 (10): 1894-1903. Grant Robert C, Denroche Robert, Jang Gun Ho, Nowak Klaudia M, Zhang Amy, Borgida Ayelet, Holter Spring, Topham James T, Wilson Julie, Dodd Anna, Jang Raymond, Prince Rebecca, Karasinska Joanna M, Schaeffer David F, Wang Yifan, Zogopoulos George, Berry Scott, Simeone Diane, Renouf Daniel J, Notta Faiyaz, O'Kane Grainne, Knox Jennifer, Fischer Sandra, Gallinger Stev |
Ruxolitinib is more effective than other JAK inhibitors to treat VEXAS syndrome: a retrospective multicenter study. Blood 2022 5 140 (8): 927-931. Heiblig Maël, Ferrada Marcela A, Koster Matthew J, Barba Thomas, Gerfaud-Valentin Mathieu, Mékinian Arsène, Coelho Henrique, Fossard Gaelle, Barraco Fiorenza, Galicier Lionel, Bienvenu Boris, Hirsch Pierre, Vial Guillaume, Boutin Anne Blandine, Galland Joris, Le Guenno Guillaume, Bigot Adrien, Warrington Kenneth J, Kermani Tanaz A, Grayson Peter C, Patel Bhavisha A, Beck David B, Jamilloux Yvan, Fenaux Pierre, Sujobert Pier |
- Page last reviewed:Feb 1, 2024
- Page last updated:May 06, 2024
- Content source: